The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Abstract
Bronchiolitis obliterans syndrome remains the leading cause of morbidity and mortality in the pulmonary transplant population. Previous studies show that macrolide antibiotics may be efficacious in the treatment of panbronchiolitis and cystic fibrosis. In the latter, azithromycin decreases the number of respiratory exacerbations, improves FEV1, and improves quality of life. We hypothesized that oral azithromycin therapy may improve lung function in patients with bronchiolitis obliterans syndrome. To test this hypothesis, we conducted an open-label pilot trial using maintenance azithromycin therapy in six lung transplant recipients (250 mg orally three times per week for a mean of 13.7 weeks). In this study, five of these six individuals demonstrated significant improvement in pulmonary function, as assessed by FEV1, as compared with their baseline values at the start of azithromycin therapy. The mean increase in the percentage of predicted FEV1 values in these individuals was 17.1% (p </= 0.05). In addition, the absolute FEV1 increased by 0.50 L (range -0.18 to 1.36 L). These data suggest a potential role for maintenance macrolide therapy in the treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
Wolter, J. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 518
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Anti-inflammatory activity of macrolide antibiotics
Michie, C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02441-3 · Cited by 356
Mycoplasma pneumoniae and Chlamydia pneumoniae in Asthma
Kraft, M., Cassell, G. H., Pak, J., & Martin, R. J. (2002) · Chest · doi:10.1378/chest.121.6.1782 · Cited by 335
Anti-Inflammatory Activity of Macrolide Antibiotics
Ianaro, A., Ialenti, A., Maffia, P., Sautebin, L., Rombolà, L., Carnuccio, R., Iuvone, T., D’Acquisto, F., & Di Rosa, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35272-3 · Cited by 309
Long-term azithromycin may improve lung function in children with cystic fibrosis
Jaffé, A., Francis, J., Rosenthal, M., & Bush, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78360-4 · Cited by 276
THE EFFECT OF ANTIMICROBIAL AGENTS ON LEUKOCYTE CHEMOTAXIS
Esterly, N. B., Furey, N. L., & Flanagan, L. E. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12543487 · Cited by 254
Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02042-3 · Cited by 234
BLACK, P. N., BLASI, F., JENKINS, C. R., SCICCHITANO, R., MILLS, G. D., RUBINFELD, A. R., RUFFIN, R. E., MULLINS, P. R., DANGAIN, J., COOPER, B. C., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2011040 · Cited by 167
Gastroesophageal Reflux as a Reversible Cause of Allograft Dysfunction After Lung Transplantation
Palmer, S. M., Miralles, A. P., Howell, D. N., Brazer, S. R., Tapson, V. F., & Davis, R. D. (2000) · Chest · doi:10.1378/chest.118.4.1214 · Cited by 161
The Influence of Azithromycin on the Biofilm Formation of Pseudomonas aeruginosa in vitro
Ichimiya, T., Takeoka, K., Hiramatsu, K., Hirai, K., Yamasaki, T., & Nasu, M. (2009) · Chemotherapy · doi:10.1159/000239440 · Cited by 156
Elssner, A., Jaumann, F., Dobmann, S., Behr, J., Schwaiblmair, M., Reichenspurner, H. C., rst, H. F., Briegel, J., & Vogelmeier, C. F. (2000) · Transplantation · doi:10.1097/00007890-200007270-00022 · Cited by 145
Lane, B. R., Markovitz, D. M., Woodford, N. L., Rochford, R. A., Strieter, R. M., & Coffey, M. (1999) · PubMed · Cited by 140
Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
Scaglione, F., & Rossoni, G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_2.47 · Cited by 131
Lane, B. R., Markovitz, D. M., Woodford, N. L., Rochford, R. A., Strieter, R. M., & Coffey, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3653 · Cited by 122
Obliterative bronchiolitis after lung and heart-lung transplantation
Reichenspurner, H. C., Girgis, R. E., Robbins, R. C., Conte, J. V., Nair, R. V., Valentine, V. G., Berry, G. J., Morris, R. E., Theodore, J., & Reitz, B. A. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00776-8 · Cited by 121
Self-citationEfficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma
Zeiger, R. S., Schatz, M. X., Sperling, W. L., et al. (1980) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(80)90003-2 · Cited by 108
Hornung, F., Scala, G., & Lenardo, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6180 · Cited by 62
Persistent Increases of BAL Neutrophils as a Predictor of Mortality Following Lung Transplant
Henke, J., Golden, J. A., Yelin, E., Keith, F. A., & Blanc, P. D. (1999) · CHEST Journal · doi:10.1378/chest.115.2.403 · Cited by 51
Donor-to-Host Transmission of Mycoplasma hominis in Lung Allograft Recipients
Gass, R., Fisher, J. H., Badesch, D. B., Zamora, M. R., Weinberg, A., Melsness, H., Grover, F. L., Tully, J. G., & Fang, F. C. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.567 · Cited by 40
Yamasaki, T., Ichimiya, T., Hirai, K., Hiramatsu, K., & Nasu, M. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.1.32 · Cited by 28
Cited by
Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.009 · Cited by 952
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Meyer, K. C., Raghu, G., Verleden, G. M., Corris, P. A., Aurora, P., Wilson, K. C., Brozek, J., Glanville, A. R., & the ISHLT/ATS/ERS BOS Task Force Committee (2014) · European Respiratory Journal · doi:10.1183/09031936.00107514 · Cited by 555
A new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Metadata
- Authors
- Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-01
- Volume
- 168
- Issue
- 1
- Pages
- 121-125
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2112046799
- Cited by
- 306
- References
- 22
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.